BV-R2 combination shows survival benefit across high-risk subgroups.
Creating a free app to assist in vancomycin dosing proved to be an entertaining and enlightening journey.
Working for the USPHS offers unique compensation and quality-of-life benefits.
There are no clearly defined, widely accepted clinical pharmacist metrics.
August marks a pivotal time for oncology pharmacy, blending transitions, celebrations, and new beginnings as professionals prepare for the upcoming season.
By interpreting and applying the data provided by algorithms, pharmacists are uniquely equipped to guide development of more patient-centered care.
By examining the evidence, pharmacists can gain insights into whether these supplements could be integrated into MS treatment regimens to improve patient outcomes.
Since the most recent guidelines were published, more evidence has emerged regarding intravenous corticosteroids for severely ill patients.
Pharmacists are integral to setting patient expectations, monitoring liver health, and ensuring adherence to long-term follow-up for optimal outcomes with etranacogene dezaparvovec.
In this retrospective study, investigators evaluated a pharmacy-led initiative in the emergency department (ED), finding a potential reduction in ED revisits and hospital readmissions, though results were not statistically significant.
Gender-affirming care and inclusive practices are essential for health equity.
These facilities provide significant value to payers and patients.
Establishing new use criteria led to an 86% reduction in the utilization of sugammadex with no appreciable impact on measured outcomes.
Abdulwhab Shremo Msdi, PharmD, BCIDP, advances research in infectious diseases and microbiome-related conditions.
Enriqueta Felip, MD, PhD, discussed the benefits of subcutaneous pembrolizumab for patients with metastatic non–small cell lung cancer.
Advances, challenges, and promising innovations emerge.
This case highlights the importance of recognizing ICPI-AKI, implementing effective therapeutic interventions, and understanding the clinical context to prevent irreversible renal damage.
Hospitals and health systems are adapting specialty and infusion pharmacy strategies to meet evolving payer mandates, rising costs, and shifting care models by expanding biosimilar use, optimizing prior authorizations, and integrating technology to enhance patient access and operational efficiency.
Relapsed treatment has evolved with CAR T, bispecific antibodies, and immunotherapies.
CKD is a complication of diabetes. Emerging treatments aim to optimize management and reduce risks. Pharmacists are key in applying new evidence to clinical practice.
Pharmacy workflow changes in the preparation of chemotherapy products can reduce patient chair time.
This interstate agreement can empower pharmacists to respond to large-scale emergencies
CDC makes groundbreaking shift by providing influenza vaccination recommendations for the geriatric population.
Knowing the benefits and effects of norgestrel can assist pharmacists when counseling patients.
Pharmacists can be instrumental in reducing the main challenges in opioid use disorder—namely supply, demand, and harm.
Redefining technician roles boosts workflow efficiencies, strengthens pharmacies' bottom lines.
Critically ill patients treated with a pharmacist-managed insulin protocol achieved higher rates of glucose control than those treated with conventional methods.
Even when safe, oral supplement use may not be appropriate to use during cancer treatment or recovery.